期刊文献+

传染性非典型肺炎理论探讨 被引量:1

The theory study of SARS in traditional Chinese medicine
下载PDF
导出
摘要 从病名、病因、病机、临床表现及治疗等几方面对非典型肺炎加以论述 。
出处 《中医药学报》 CAS 2004年第5期1-4,共4页 Acta Chinese Medicine and Pharmacology
  • 引文网络
  • 相关文献

参考文献18

二级参考文献37

  • 1.[Z].,..
  • 2传染性非典型肺炎防治培训教材.中国疾病预防控制中心编写中国协和医科大学出版社出版[M].,2003.141-146.
  • 3李太生 邱志峰 韩杨 等.严重急性呼吸综合征发病机理初探[J].中国医学论坛报SARS研究进展,2003,2003:40-42.
  • 4[1]Grasela DM. Clinical pharmacology of gatifloxacin, a new fluoroquinolone[J]. Clin Infect Dis, 2000, 31(Suppl 2): S51-58
  • 5[2]Perry CM, Ormrod D, Hurst M, et al. Gatifloxacin: a review of its use in the management of bacterial infections[J]. Drugs, 2002, 62: 169-207
  • 6[3]Bartlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community-acquired pneumonia in adults[J]. Clin Infect Dis, 2000, 31: 347-382
  • 7[4]Niederman MS, Momdell CA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention[J]. Am J Respir Crit Care Med, 2001, 163: 1730-1754
  • 8[5]Pankuch GA, Jacobs MR, Appelbaum PC. Postantibiotic effects of gatifloxacin against Gram-positive and negative organisms[J]. Antimicrob Agents Chemother, 1999, 43: 2574-2575
  • 9[6]Sullivan JG, McElroy AD, Honsinger RW, et al. Treating community-acquired pneumonia with once-daily gatifloxacin vs once-daily levofloxacin[J]. J Respir Dis, 1999, 20(suppl): S49-S59
  • 10[7]Breen J, Skuba K, Grasela D. Safety and tolerability of gatifloxacin, an advanced-generation, 8-methoxy fluoroquinolone[J]. J Respir Dis, 1999, 20(suppl): s70-s75

共引文献310

同被引文献44

引证文献1

二级引证文献5

;
使用帮助 返回顶部